HIV-Impfstoffentwicklung: Bessere Antikörper durch Keimbahntargeting
La Jolla/Cambridge – Bei der Entwicklung eines Impfstoffs gegen HIV wollen Forschende die Produktion besonders wirksamer Antikörper jetzt nicht ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.